| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tango Therapeutics, Inc. (TNGX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. TNGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.39M | $314.32M | - | |
| Pres | 368.0K | $8.64M | -27,000 | |
| CEO | 367.5K | $8.63M | - | |
| CFO | 40.0K | $939.2K | - | |
| Dir | 37.5K | $880.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Crystal Adam78 | President, R&D | Sale+OE | 27,000 | $21.23 | $573,097.33 | -10.4% | - | - | |
| Mar 25, 2026 | Crystal Adam78 | President, R&D | Sale+OE | 12,000 | $20.11 | $241,320.00 | -9.6% | - | - | |
| Oct 23, 2025 | Third Rock Ventures Iv, L.P.69 | 10% Owner | Sell | 477,401 | $10.15 | $4,846,574.95 | -3.4% | +66.1% | - | |
| Sep 25, 2025 | Third Rock Ventures Iv, L.P.69 | 10% Owner | Sell | 500,000 | $8.02 | $4,008,500.00 | -3.5% | +9.2% | - | |
| Sep 16, 2025 | Third Rock Ventures Iv, L.P.69 | 10% Owner | Sell | 363,541 | $7.04 | $2,559,328.64 | -2.5% | +24.1% | - | |
| Sep 8, 2025 | Third Rock Ventures Iv, L.P.69 | 10% Owner | Sell | 729,365 | $7.00 | $5,108,970.13 | -2.4% | +41.0% | - | |
| Aug 22, 2025 | Third Rock Ventures Iv, L.P.69 | 10% Owner | Sell | 302,194 | $7.00 | $2,115,358.00 | -1.9% | +29.0% | - | |
| Aug 19, 2025 | Third Rock Ventures Iv, L.P.69 | 10% Owner | Sell | 1,100,000 | $7.01 | $7,712,760.00 | -6.5% | +14.7% | - | |
| Feb 5, 2025 | Barry Douglas54 | General Counsel | Sell | 5,330 | $3.07 | $16,369.25 | -3.8% | -62.4% | +256.7% | |
| Feb 5, 2025 | Beckman Daniella52 | Chief Financial Officer | Sell | 8,232 | $3.07 | $25,281.80 | -2.6% | -62.4% | +256.7% |